Furthermore, high baseline eosinophil count, serum ECP, and eosinophil peroxidase levels were associated with prolonged progression-free survival (PFS) in metastatic melanoma under immune checkpoint inhibition (20). The gene discussed is RNASE3; the disease is metastatic melanoma.